Editorial: Drug development of herbal medicines: Regulatory perspectives.
- DOI
- 10.3389/fphar.2022.989934
- Published
- 2022
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2022.989934,
title = {Editorial: Drug development of herbal medicines: Regulatory perspectives.},
author = {Bilia AR and Mukherjee PK and Andrade-Cetto A and Katiyar CK and Bachar SC and Matsabisa MG and Mandal SC},
year = {2022},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2022.989934},
url = {https://doi.org/10.3389/fphar.2022.989934}
}RIS
TY - JOUR TI - Editorial: Drug development of herbal medicines: Regulatory perspectives. AU - Bilia AR AU - Mukherjee PK AU - Andrade-Cetto A AU - Katiyar CK AU - Bachar SC AU - Matsabisa MG AU - Mandal SC PY - 2022 JO - Frontiers in pharmacology DO - 10.3389/fphar.2022.989934 UR - https://doi.org/10.3389/fphar.2022.989934 ER -
APA
AR, B., PK, M., A, A., CK, K., SC, B., MG, M., & SC, M. (2022). Editorial: Drug development of herbal medicines: Regulatory perspectives.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2022.989934
Source records
- pubmed · retrieved 2026-09-26T08:28:44.604Z